What does Zhejiang East Asia Pharmaceutical Co., Ltd. do?

Zhejiang East Asia Pharmaceutical Co., Ltd. (605177.SS) operates in the Biotechnology industry within the Healthcare sector. Full company description, peers, and segment breakdown are on the page above.

What is 605177.SS's market cap?

Zhejiang East Asia Pharmaceutical Co., Ltd. (605177.SS) has a market capitalization of approximately $2.26 billion, as of August 26, 2026, based on the most recent share price and shares outstanding.

Does 605177.SS pay a dividend?

Yes — Zhejiang East Asia Pharmaceutical Co., Ltd. (605177.SS) has a dividend payment history. The most recent payment, frequency, and full history are on the Dividend tab.

Is 605177.SS profitable?

Zhejiang East Asia Pharmaceutical Co., Ltd. (605177.SS) currently reports negative earnings on a trailing-twelve-month basis. The Earnings and Financials tabs show the full EPS history, revenue trend, and analyst forecasts for future profitability.

605177.SS

Zhejiang East Asia Pharmaceutical Co., Ltd.

SHH·Biotechnology · Healthcare

¥20.09¥0.29−1.42%

Market cap¥2.26B·Market closed·Aug 26 7:00 AM UTC

Price Chart

¥20.09−¥0.29 (−1.42%)today

−33.32%CAGR −7.79%

Select date range

FromTo

Nov 25, 2020Aug 26, 2021 → Aug 26, 2026· 5.0 yrsAug 26, 2026

Key Metrics

DividendDividend Tab

Dividend Yield (FWD)0.00%

Annual Dividend (FWD)¥0.00

Dividend Growth (5Y)—

Dividend Safety—

Payout Ratio—

FCF Payout Ratio—

Most Recent Dividend¥0.327

Ex-Dividend DateJul 4

Payment DateJul 4

EarningsEarnings Tab

EPS (FWD)—

P/E Ratio (FWD)—

EPS Growth (1Y)—

EPS Growth (3Y)—

EPS Growth (5Y)—

Next Earnings DateOct 31

Last Report DateApr 29

Reported vs Estimate−¥0.31

Earnings Surprise—

FinancialsFinancials Tab

Revenue¥1.01B

Net Income−¥110.67M

Net Margin−10.9%

Operating Cash Flow−¥100.44M

Capital Expenditures¥48.65M

Free Cash Flow−¥149.09M

Return on Equity−6.2%

Return on Invested Capital−1.1%

Net Debt¥652.02M

Value Graph

PRO

See price against where its own fundamentals say it should trade — the shaded gap is the discount or premium, across five valuation lenses.

Click below to see what's inside, then upgrade to unlock for 605177.SS and 80,000+ other tickers.

EPS · Price vs. Fair Value Price Fair

Income Statement Flow

PRO

See exactly how 605177.SS's revenue becomes profit — a Sankey that traces revenue (and its reported segments) through gross profit, operating expenses, and net profit, with the year-over-year change on every line.

The same diagram the Chart Builder draws, right on the Summary tab. Upgrade to unlock it for 605177.SS and 80,000+ other tickers.

About Zhejiang East Asia Pharmaceutical Co., Ltd.

Founded in 1992, Zhejiang East Asia Pharmaceutical Co., Ltd. operates in the manufacture and supply of active pharmaceutical ingredients (APIs), tablets, granules, and capsules. The company's principal office is situated in Taizhou, China.

CEO: Cheng Chi
Sector: Healthcare
Industry: Biotechnology
Exchange: SHH
Employees: 1,514
Website: www.eapharm.cn

Peers

Peers Tab

300878.SZ

Zhejiang Wecome Pharmaceutical Company Limited

Cap

¥4.6B

002566.SZ

Jilin Jian Yisheng Pharmaceutical Co., Ltd.

Cap

¥2.3B

000518.SZ

Jiangsu Sihuan Bioengineering Co., Ltd

Cap

¥4.0B

Latest News

News Tab

No recent news available.

Frequently Asked Questions About 605177.SS

What does Zhejiang East Asia Pharmaceutical Co., Ltd. do?: Zhejiang East Asia Pharmaceutical Co., Ltd. (605177.SS) operates in the Biotechnology industry within the Healthcare sector. Full company description, peers, and segment breakdown are on the page above.
What is 605177.SS's market cap?: Zhejiang East Asia Pharmaceutical Co., Ltd. (605177.SS) has a market capitalization of approximately $2.26 billion, as of August 26, 2026, based on the most recent share price and shares outstanding.
Does 605177.SS pay a dividend?: Yes — Zhejiang East Asia Pharmaceutical Co., Ltd. (605177.SS) has a dividend payment history. The most recent payment, frequency, and full history are on the Dividend tab.
Is 605177.SS profitable?: Zhejiang East Asia Pharmaceutical Co., Ltd. (605177.SS) currently reports negative earnings on a trailing-twelve-month basis. The Earnings and Financials tabs show the full EPS history, revenue trend, and analyst forecasts for future profitability.